{"transactions":[{"id":749262,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2026-06-04T20:05:20.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":1764,"price":2.19,"value":3863.16,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant."}],"balance_after":13290,"derivative":{"exercise_price":2.19,"exercise_date":"2027-06-03","expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":1764},"source":{"system":"sec-edgar","filing":"0001493152-26-027259","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226027259/ownership.xml","form_type":"4"}},{"id":1120954,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2025-06-05T20:07:01.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":1764,"price":3.2,"value":5644.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant."}],"balance_after":11526,"derivative":{"exercise_price":3.2,"exercise_date":"2026-06-04","expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":1764},"source":{"system":"sec-edgar","filing":"0001641172-25-013796","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000164117225013796/ownership.xml","form_type":"4"}},{"id":1486208,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2024-06-07T21:45:33.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":1764,"price":7.05,"value":12436.2,"ownership":{"direct":true},"balance_after":10938,"derivative":{"exercise_price":7.05,"exercise_date":"2025-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":1764},"source":{"system":"sec-edgar","filing":"0001493152-24-023213","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315224023213/ownership.xml","form_type":"4"}},{"id":1894731,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2023-05-12T20:35:45.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0.2656,"value":7968.0,"ownership":{"direct":true},"balance_after":166000,"derivative":{"exercise_price":0.2656,"exercise_date":"2024-05-10","expiration_date":"2033-05-10","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-23-016690","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315223016690/ownership.xml","form_type":"4"}},{"id":1944155,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-20T22:51:33.000Z","date":"2023-03-20","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":0.34,"value":1360.0,"ownership":{"direct":true},"balance_after":14125,"source":{"system":"sec-edgar","filing":"0001493152-23-008304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315223008304/ownership.xml","form_type":"4"}},{"id":2235478,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2022-06-10T15:36:00.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":22000,"price":0.92,"value":20240.0,"ownership":{"direct":true},"balance_after":136000,"derivative":{"exercise_price":0.92,"exercise_date":"2023-06-08","expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001493152-22-016406","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222016406/ownership.xml","form_type":"4"}},{"id":2673444,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2021-06-10T18:44:05.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":22000,"price":1.26,"value":27720.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant"}],"balance_after":22000,"derivative":{"exercise_price":1.26,"exercise_date":"2022-06-09","expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001638599-21-000539","document":"doc4_7261.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859921000539/doc4_7261.xml","form_type":"4"}},{"id":2931728,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2020-12-28T21:30:31.000Z","date":"2020-12-22","kind":"grant","acquired":true,"shares":754839,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":754839,"derivative":{"exercise_price":0.031,"exercise_date":"2020-12-22","expiration_date":"2030-12-22","underlying":"Common Stock","underlying_shares":754839},"source":{"system":"sec-edgar","filing":"0000899243-20-035201","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924320035201/doc4.xml","form_type":"4"}},{"id":2939431,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-12-17T21:07:21.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO."}],"balance_after":5250,"derivative":{"exercise_price":0,"exercise_date":"2020-12-16","expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":5250},"source":{"system":"sec-edgar","filing":"0001638599-20-000980","document":"doc4_6963.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000980/doc4_6963.xml","form_type":"4"}},{"id":2939430,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-17T21:07:21.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."}],"balance_after":10125,"source":{"system":"sec-edgar","filing":"0001638599-20-000980","document":"doc4_6963.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000980/doc4_6963.xml","form_type":"4"}},{"id":3114373,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-10T20:10:43.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":22000,"price":0.9629,"value":21183.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant"}],"balance_after":22000,"derivative":{"exercise_price":0.9629,"exercise_date":"2021-06-10","expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001638599-20-000591","document":"doc4_6753.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859920000591/doc4_6753.xml","form_type":"4"}},{"id":3196753,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2020-03-24T13:02:47.000Z","date":"2020-03-20","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1000000,"derivative":{"exercise_price":0.05,"exercise_date":"2021-03-20","expiration_date":"2030-03-20","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0000899243-20-009312","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924320009312/doc4.xml","form_type":"4"}},{"id":3489356,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-14T15:10:48.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":10000,"price":1.68,"value":16800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant"}],"balance_after":10000,"derivative":{"exercise_price":1.68,"exercise_date":"2020-06-12","expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001638599-19-000609","document":"doc4_6153.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859919000609/doc4_6153.xml","form_type":"4"}},{"id":3674990,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2019-02-06T00:57:48.000Z","date":"2019-02-03","kind":"grant","acquired":true,"shares":657895,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":657895,"derivative":{"exercise_price":0.076,"exercise_date":"2020-02-03","expiration_date":"2029-02-03","underlying":"Common Stock","underlying_shares":657895},"source":{"system":"sec-edgar","filing":"0000899243-19-002715","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924319002715/doc4.xml","form_type":"4"}},{"id":3881186,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stcck Optoin (right to buy)","published_at":"2018-06-28T16:29:20.000Z","date":"2018-06-27","kind":"grant","acquired":true,"shares":20000,"price":1.33,"value":26600.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant"}],"balance_after":20000,"derivative":{"exercise_price":1.33,"exercise_date":"2019-06-27","expiration_date":"2028-06-27","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001638599-18-000699","document":"doc4_5501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859918000699/doc4_5501.xml","form_type":"4"}},{"id":3994951,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2018-03-15T21:07:02.000Z","date":"2018-03-13","kind":"grant","acquired":true,"shares":56000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":56000,"derivative":{"exercise_price":0.2722,"exercise_date":"2018-03-13","expiration_date":"2028-03-13","underlying":"Common Stock","underlying_shares":56000},"source":{"system":"sec-edgar","filing":"0000899243-18-007587","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924318007587/doc4.xml","form_type":"4"}},{"id":3994950,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2018-03-15T21:07:02.000Z","date":"2018-03-13","kind":"grant","acquired":true,"shares":253000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These options were granted subject to the approval of the majority stockholder of the registrant pursuant to an agreement between the majority stockholder and the registrant. In the event that the majority stockholder does not approve the option grant, the options will be canceled."}],"balance_after":253000,"derivative":{"exercise_price":0.2722,"exercise_date":"2019-03-13","expiration_date":"2028-03-13","underlying":"Common Stock","underlying_shares":253000},"source":{"system":"sec-edgar","filing":"0000899243-18-007587","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924318007587/doc4.xml","form_type":"4"}},{"id":4116822,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-01-02T23:15:28.000Z","date":"2017-12-29","kind":"exercise","acquired":false,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 29, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 29, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021."}],"balance_after":5250,"derivative":{"exercise_price":0,"exercise_date":"2017-12-29","expiration_date":"2027-01-25","underlying":"Common stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001638599-18-000026","document":"doc4_5174.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859918000026/doc4_5174.xml","form_type":"4"}},{"id":4116821,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2018-01-02T23:15:28.000Z","date":"2017-12-29","kind":"sale","acquired":false,"shares":875,"price":3.4667,"value":3033.3625,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average price of shares sold at a price that ranged from $3.43-$3.54."}],"balance_after":4875,"source":{"system":"sec-edgar","filing":"0001638599-18-000026","document":"doc4_5174.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859918000026/doc4_5174.xml","form_type":"4"}},{"id":4116820,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-02T23:15:28.000Z","date":"2017-12-29","kind":"exercise","acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units (see footnote 4)."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units (see footnote 4)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units (see footnote 4)."}],"balance_after":5750,"source":{"system":"sec-edgar","filing":"0001638599-18-000026","document":"doc4_5174.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859918000026/doc4_5174.xml","form_type":"4"}},{"id":4391034,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-03-10T21:15:33.000Z","date":"2017-03-08","kind":"exercise","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs were issued to the reporting person on July 1, 2016, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs were issued to the reporting person on July 1, 2016, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000899243-17-007150","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924317007150/doc4.xml","form_type":"4"}},{"id":4391033,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-03-10T21:15:33.000Z","date":"2017-03-08","kind":"exercise","acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were issued to the reporting person on August 14, 2015, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were issued to the reporting person on August 14, 2015, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000899243-17-007150","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924317007150/doc4.xml","form_type":"4"}},{"id":4391032,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-03-10T21:15:33.000Z","date":"2017-03-08","kind":"exercise","acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were issued to the reporting person on July 18, 2014, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were issued to the reporting person on July 18, 2014, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000899243-17-007150","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924317007150/doc4.xml","form_type":"4"}},{"id":4391031,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-10T21:15:33.000Z","date":"2017-03-08","kind":"tax_withholding","acquired":false,"shares":59400,"price":0.34,"value":20196.0,"ownership":{"direct":true},"balance_after":453000,"source":{"system":"sec-edgar","filing":"0000899243-17-007150","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924317007150/doc4.xml","form_type":"4"}},{"id":4391030,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-10T21:15:33.000Z","date":"2017-03-08","kind":"exercise","acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The RSUs were issued to the reporting person on July 1, 2016, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms."}],"balance_after":512400,"source":{"system":"sec-edgar","filing":"0000899243-17-007150","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924317007150/doc4.xml","form_type":"4"}},{"id":4391029,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-10T21:15:33.000Z","date":"2017-03-08","kind":"tax_withholding","acquired":false,"shares":118800,"price":0.34,"value":40392.0,"ownership":{"direct":true},"balance_after":362400,"source":{"system":"sec-edgar","filing":"0000899243-17-007150","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924317007150/doc4.xml","form_type":"4"}},{"id":4391028,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-10T21:15:33.000Z","date":"2017-03-08","kind":"exercise","acquired":true,"shares":300000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The RSUs were issued to the reporting person on August 14, 2015, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms."}],"balance_after":481200,"source":{"system":"sec-edgar","filing":"0000899243-17-007150","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924317007150/doc4.xml","form_type":"4"}},{"id":4391027,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-10T21:15:33.000Z","date":"2017-03-08","kind":"tax_withholding","acquired":false,"shares":118800,"price":0.34,"value":40392.0,"ownership":{"direct":true},"balance_after":181200,"source":{"system":"sec-edgar","filing":"0000899243-17-007150","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924317007150/doc4.xml","form_type":"4"}},{"id":4391026,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-10T21:15:33.000Z","date":"2017-03-08","kind":"exercise","acquired":true,"shares":300000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were issued to the reporting person on July 18, 2014, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0000899243-17-007150","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924317007150/doc4.xml","form_type":"4"}},{"id":4477007,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41246,"kind":"person","name":"Ono Richard Dana","position":1,"cik":"0001595989","reported_name":"Ono Richard Dana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-01-31T02:39:59.000Z","date":"2017-01-26","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021."}],"balance_after":7000,"derivative":{"exercise_price":0,"exercise_date":"2017-12-31","expiration_date":"2027-01-25","underlying":"Common stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001638599-17-000126","document":"doc4_4501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859917000126/doc4_4501.xml","form_type":"4"}}]}